Answers are grounded in this paper and cite their sources.
Prospective cohort study demonstrates T2 and DWI-IVIM distinguish strictures in Crohn's disease, suggesting potential clinical use.
T2* could serve as a biomarker for distinguishing inflammatory from noninflammatory strictures in Crohn's disease. Diffusion measured by IVIM can distinguish inflammatory from noninflammatory strictures in Crohn's disease. Muscularisation was more prominent than fibrosis in strictures due to Crohn's disease.
No takes yet. Share an insight, caveat, or question.
Beek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: